SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SLV-154 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SLV-154 in about 70 people with advanced solid tumors (like head and neck, lung, breast, or ovarian cancer) that have spread. The main goal is to find a safe dose and check for side effects. Researchers will also watch for any signs …
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New trial tests if adding chemo to radiation boosts survival for head and neck cancer patients
Disease control Recruiting nowThis phase 3 trial aims to see if adding chemotherapy (cisplatin) to standard radiation therapy after surgery helps people with intermediate-risk head and neck squamous cell carcinoma live longer without the cancer returning. About 386 participants who have had surgery and show c…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Recruiting nowThis early-stage trial tests a fluorescent dye attached to the cancer drug nivolumab. The dye is meant to make cancer cells glow during surgery, helping surgeons remove them more precisely. The study will enroll 40 people with head and neck cancer who are already scheduled for su…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
New daily adaptive radiotherapy aims to spare saliva glands in head and neck cancer patients
Symptom relief Recruiting nowThis phase II trial tests whether daily adaptive radiotherapy (DART) can better protect the submandibular glands during head and neck cancer treatment compared to standard image-guided radiation. About 50 participants will be randomly assigned to receive either standard or adapti…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Sound waves zapped into brain to kill cancer pain without drugs
Symptom relief Recruiting nowThis early-stage study tests a non-invasive procedure that uses focused ultrasound to create a tiny lesion in the brain's pain center. It is for 20 adults with head, neck, or brachial cancer whose pain is not controlled by opioids. The goal is to see if it is safe and can reduce …
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC